<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Circulating-Tumor-Dna on 生物经济</title><link>https://cn.bioecon.ru/technologies/circulating-tumor-dna/</link><description>Recent content in Circulating-Tumor-Dna on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Mon, 20 Jul 2026 14:07:15 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/circulating-tumor-dna/index.xml" rel="self" type="application/rss+xml"/><item><title>液体活检与 ctDNA 诊断</title><link>https://cn.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/</guid><description>通过血液检测与定量循环肿瘤DNA（ctDNA），用于癌症伴随诊断与微小残留病灶（MRD）监测，替代或补充组织活检——以美国 Guardant Health、Natera、Foundation Medicine，欧盟 Sysmex Inostics，印度 MedGenome，以及中国燃石医学为代表。</description></item></channel></rss>